Global Monovalent Antivenom Supply, Demand and Key Producers, 2024-2030
Page: 111
Published Date: 19 Feb 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Monovalent Antivenom market size is expected to reach $ 484.8 million by 2030, rising at a market growth of 3.0% CAGR during the forecast period (2024-2030).
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
This report studies the global Monovalent Antivenom production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Monovalent Antivenom, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Monovalent Antivenom that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Monovalent Antivenom total production and demand, 2019-2030, (K Units)
Global Monovalent Antivenom total production value, 2019-2030, (USD Million)
Global Monovalent Antivenom production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Monovalent Antivenom consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Monovalent Antivenom domestic production, consumption, key domestic manufacturers and share
Global Monovalent Antivenom production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Monovalent Antivenom production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Monovalent Antivenom production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Monovalent Antivenom market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Vins Bioproducts and Serum Biotech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Monovalent Antivenom market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Monovalent Antivenom Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Monovalent Antivenom Market, Segmentation by Type
Coral Snakes Antivenom
Sea Snakes Antivenom
Brown Snake Antivenom
Others
Global Monovalent Antivenom Market, Segmentation by Application
Non-profit Institutions
Hospitals and Clinic
Companies Profiled:
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Vins Bioproducts
Serum Biotech
Key Questions Answered
1. How big is the global Monovalent Antivenom market?
2. What is the demand of the global Monovalent Antivenom market?
3. What is the year over year growth of the global Monovalent Antivenom market?
4. What is the production and production value of the global Monovalent Antivenom market?
5. Who are the key producers in the global Monovalent Antivenom market?
Table of Contents
1 Supply Summary
1.1 Monovalent Antivenom Introduction
1.2 World Monovalent Antivenom Supply & Forecast
1.2.1 World Monovalent Antivenom Production Value (2019 & 2023 & 2030)
1.2.2 World Monovalent Antivenom Production (2019-2030)
1.2.3 World Monovalent Antivenom Pricing Trends (2019-2030)
1.3 World Monovalent Antivenom Production by Region (Based on Production Site)
1.3.1 World Monovalent Antivenom Production Value by Region (2019-2030)
1.3.2 World Monovalent Antivenom Production by Region (2019-2030)
1.3.3 World Monovalent Antivenom Average Price by Region (2019-2030)
1.3.4 North America Monovalent Antivenom Production (2019-2030)
1.3.5 Europe Monovalent Antivenom Production (2019-2030)
1.3.6 China Monovalent Antivenom Production (2019-2030)
1.3.7 Japan Monovalent Antivenom Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Monovalent Antivenom Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Monovalent Antivenom Major Market Trends
2.1 World Monovalent Antivenom Demand (2019-2030)
2.2 World Monovalent Antivenom Consumption by Region
2.2.1 World Monovalent Antivenom Consumption by Region (2019-2024)
2.2.2 World Monovalent Antivenom Consumption Forecast by Region (2025-2030)
2.3 United States Monovalent Antivenom Consumption (2019-2030)
2.4 China Monovalent Antivenom Consumption (2019-2030)
2.5 Europe Monovalent Antivenom Consumption (2019-2030)
2.6 Japan Monovalent Antivenom Consumption (2019-2030)
2.7 South Korea Monovalent Antivenom Consumption (2019-2030)
2.8 ASEAN Monovalent Antivenom Consumption (2019-2030)
2.9 India Monovalent Antivenom Consumption (2019-2030)
3.1 World Monovalent Antivenom Production Value by Manufacturer (2019-2024)
3.2 World Monovalent Antivenom Production by Manufacturer (2019-2024)
3.3 World Monovalent Antivenom Average Price by Manufacturer (2019-2024)
3.4 Monovalent Antivenom Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Monovalent Antivenom Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Monovalent Antivenom in 2023
3.5.3 Global Concentration Ratios (CR8) for Monovalent Antivenom in 2023
3.6 Monovalent Antivenom Market: Overall Company Footprint Analysis
3.6.1 Monovalent Antivenom Market: Region Footprint
3.6.2 Monovalent Antivenom Market: Company Product Type Footprint
3.6.3 Monovalent Antivenom Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Monovalent Antivenom Production Value Comparison
4.1.1 United States VS China: Monovalent Antivenom Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Monovalent Antivenom Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Monovalent Antivenom Production Comparison
4.2.1 United States VS China: Monovalent Antivenom Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Monovalent Antivenom Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Monovalent Antivenom Consumption Comparison
4.3.1 United States VS China: Monovalent Antivenom Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Monovalent Antivenom Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Monovalent Antivenom Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Monovalent Antivenom Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Monovalent Antivenom Production Value (2019-2024)
4.4.3 United States Based Manufacturers Monovalent Antivenom Production (2019-2024)
4.5 China Based Monovalent Antivenom Manufacturers and Market Share
4.5.1 China Based Monovalent Antivenom Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Monovalent Antivenom Production Value (2019-2024)
4.5.3 China Based Manufacturers Monovalent Antivenom Production (2019-2024)
4.6 Rest of World Based Monovalent Antivenom Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Monovalent Antivenom Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Monovalent Antivenom Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Monovalent Antivenom Production (2019-2024)
5.1 World Monovalent Antivenom Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Coral Snakes Antivenom
5.2.2 Sea Snakes Antivenom
5.2.3 Brown Snake Antivenom
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Monovalent Antivenom Production by Type (2019-2030)
5.3.2 World Monovalent Antivenom Production Value by Type (2019-2030)
5.3.3 World Monovalent Antivenom Average Price by Type (2019-2030)
6.1 World Monovalent Antivenom Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Non-profit Institutions
6.2.2 Hospitals and Clinic
6.3 Market Segment by Application
6.3.1 World Monovalent Antivenom Production by Application (2019-2030)
6.3.2 World Monovalent Antivenom Production Value by Application (2019-2030)
6.3.3 World Monovalent Antivenom Average Price by Application (2019-2030)
7.1 CSL
7.1.1 CSL Details
7.1.2 CSL Major Business
7.1.3 CSL Monovalent Antivenom Product and Services
7.1.4 CSL Monovalent Antivenom Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 CSL Recent Developments/Updates
7.1.6 CSL Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Monovalent Antivenom Product and Services
7.2.4 Merck Monovalent Antivenom Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 BTG
7.3.1 BTG Details
7.3.2 BTG Major Business
7.3.3 BTG Monovalent Antivenom Product and Services
7.3.4 BTG Monovalent Antivenom Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 BTG Recent Developments/Updates
7.3.6 BTG Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Monovalent Antivenom Product and Services
7.4.4 Pfizer Monovalent Antivenom Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 Haffkine Bio-Pharmaceutical
7.5.1 Haffkine Bio-Pharmaceutical Details
7.5.2 Haffkine Bio-Pharmaceutical Major Business
7.5.3 Haffkine Bio-Pharmaceutical Monovalent Antivenom Product and Services
7.5.4 Haffkine Bio-Pharmaceutical Monovalent Antivenom Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
7.5.6 Haffkine Bio-Pharmaceutical Competitive Strengths & Weaknesses
7.6 Vins Bioproducts
7.6.1 Vins Bioproducts Details
7.6.2 Vins Bioproducts Major Business
7.6.3 Vins Bioproducts Monovalent Antivenom Product and Services
7.6.4 Vins Bioproducts Monovalent Antivenom Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Vins Bioproducts Recent Developments/Updates
7.6.6 Vins Bioproducts Competitive Strengths & Weaknesses
7.7 Serum Biotech
7.7.1 Serum Biotech Details
7.7.2 Serum Biotech Major Business
7.7.3 Serum Biotech Monovalent Antivenom Product and Services
7.7.4 Serum Biotech Monovalent Antivenom Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Serum Biotech Recent Developments/Updates
7.7.6 Serum Biotech Competitive Strengths & Weaknesses
8.1 Monovalent Antivenom Industry Chain
8.2 Monovalent Antivenom Upstream Analysis
8.2.1 Monovalent Antivenom Core Raw Materials
8.2.2 Main Manufacturers of Monovalent Antivenom Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Monovalent Antivenom Production Mode
8.6 Monovalent Antivenom Procurement Model
8.7 Monovalent Antivenom Industry Sales Model and Sales Channels
8.7.1 Monovalent Antivenom Sales Model
8.7.2 Monovalent Antivenom Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Monovalent Antivenom Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Monovalent Antivenom Production Value by Region (2019-2024) & (USD Million)
Table 3. World Monovalent Antivenom Production Value by Region (2025-2030) & (USD Million)
Table 4. World Monovalent Antivenom Production Value Market Share by Region (2019-2024)
Table 5. World Monovalent Antivenom Production Value Market Share by Region (2025-2030)
Table 6. World Monovalent Antivenom Production by Region (2019-2024) & (K Units)
Table 7. World Monovalent Antivenom Production by Region (2025-2030) & (K Units)
Table 8. World Monovalent Antivenom Production Market Share by Region (2019-2024)
Table 9. World Monovalent Antivenom Production Market Share by Region (2025-2030)
Table 10. World Monovalent Antivenom Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Monovalent Antivenom Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Monovalent Antivenom Major Market Trends
Table 13. World Monovalent Antivenom Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Monovalent Antivenom Consumption by Region (2019-2024) & (K Units)
Table 15. World Monovalent Antivenom Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Monovalent Antivenom Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Monovalent Antivenom Producers in 2023
Table 18. World Monovalent Antivenom Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Monovalent Antivenom Producers in 2023
Table 20. World Monovalent Antivenom Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Monovalent Antivenom Company Evaluation Quadrant
Table 22. World Monovalent Antivenom Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Monovalent Antivenom Production Site of Key Manufacturer
Table 24. Monovalent Antivenom Market: Company Product Type Footprint
Table 25. Monovalent Antivenom Market: Company Product Application Footprint
Table 26. Monovalent Antivenom Competitive Factors
Table 27. Monovalent Antivenom New Entrant and Capacity Expansion Plans
Table 28. Monovalent Antivenom Mergers & Acquisitions Activity
Table 29. United States VS China Monovalent Antivenom Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Monovalent Antivenom Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Monovalent Antivenom Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Monovalent Antivenom Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Monovalent Antivenom Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Monovalent Antivenom Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Monovalent Antivenom Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Monovalent Antivenom Production Market Share (2019-2024)
Table 37. China Based Monovalent Antivenom Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Monovalent Antivenom Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Monovalent Antivenom Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Monovalent Antivenom Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Monovalent Antivenom Production Market Share (2019-2024)
Table 42. Rest of World Based Monovalent Antivenom Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Monovalent Antivenom Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Monovalent Antivenom Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Monovalent Antivenom Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Monovalent Antivenom Production Market Share (2019-2024)
Table 47. World Monovalent Antivenom Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Monovalent Antivenom Production by Type (2019-2024) & (K Units)
Table 49. World Monovalent Antivenom Production by Type (2025-2030) & (K Units)
Table 50. World Monovalent Antivenom Production Value by Type (2019-2024) & (USD Million)
Table 51. World Monovalent Antivenom Production Value by Type (2025-2030) & (USD Million)
Table 52. World Monovalent Antivenom Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Monovalent Antivenom Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Monovalent Antivenom Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Monovalent Antivenom Production by Application (2019-2024) & (K Units)
Table 56. World Monovalent Antivenom Production by Application (2025-2030) & (K Units)
Table 57. World Monovalent Antivenom Production Value by Application (2019-2024) & (USD Million)
Table 58. World Monovalent Antivenom Production Value by Application (2025-2030) & (USD Million)
Table 59. World Monovalent Antivenom Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Monovalent Antivenom Average Price by Application (2025-2030) & (US$/Unit)
Table 61. CSL Basic Information, Manufacturing Base and Competitors
Table 62. CSL Major Business
Table 63. CSL Monovalent Antivenom Product and Services
Table 64. CSL Monovalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. CSL Recent Developments/Updates
Table 66. CSL Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Monovalent Antivenom Product and Services
Table 70. Merck Monovalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. BTG Basic Information, Manufacturing Base and Competitors
Table 74. BTG Major Business
Table 75. BTG Monovalent Antivenom Product and Services
Table 76. BTG Monovalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. BTG Recent Developments/Updates
Table 78. BTG Competitive Strengths & Weaknesses
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Major Business
Table 81. Pfizer Monovalent Antivenom Product and Services
Table 82. Pfizer Monovalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Pfizer Recent Developments/Updates
Table 84. Pfizer Competitive Strengths & Weaknesses
Table 85. Haffkine Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 86. Haffkine Bio-Pharmaceutical Major Business
Table 87. Haffkine Bio-Pharmaceutical Monovalent Antivenom Product and Services
Table 88. Haffkine Bio-Pharmaceutical Monovalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Haffkine Bio-Pharmaceutical Recent Developments/Updates
Table 90. Haffkine Bio-Pharmaceutical Competitive Strengths & Weaknesses
Table 91. Vins Bioproducts Basic Information, Manufacturing Base and Competitors
Table 92. Vins Bioproducts Major Business
Table 93. Vins Bioproducts Monovalent Antivenom Product and Services
Table 94. Vins Bioproducts Monovalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Vins Bioproducts Recent Developments/Updates
Table 96. Serum Biotech Basic Information, Manufacturing Base and Competitors
Table 97. Serum Biotech Major Business
Table 98. Serum Biotech Monovalent Antivenom Product and Services
Table 99. Serum Biotech Monovalent Antivenom Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 100. Global Key Players of Monovalent Antivenom Upstream (Raw Materials)
Table 101. Monovalent Antivenom Typical Customers
Table 102. Monovalent Antivenom Typical Distributors
List of Figure
Figure 1. Monovalent Antivenom Picture
Figure 2. World Monovalent Antivenom Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Monovalent Antivenom Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Monovalent Antivenom Production (2019-2030) & (K Units)
Figure 5. World Monovalent Antivenom Average Price (2019-2030) & (US$/Unit)
Figure 6. World Monovalent Antivenom Production Value Market Share by Region (2019-2030)
Figure 7. World Monovalent Antivenom Production Market Share by Region (2019-2030)
Figure 8. North America Monovalent Antivenom Production (2019-2030) & (K Units)
Figure 9. Europe Monovalent Antivenom Production (2019-2030) & (K Units)
Figure 10. China Monovalent Antivenom Production (2019-2030) & (K Units)
Figure 11. Japan Monovalent Antivenom Production (2019-2030) & (K Units)
Figure 12. Monovalent Antivenom Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Monovalent Antivenom Consumption (2019-2030) & (K Units)
Figure 15. World Monovalent Antivenom Consumption Market Share by Region (2019-2030)
Figure 16. United States Monovalent Antivenom Consumption (2019-2030) & (K Units)
Figure 17. China Monovalent Antivenom Consumption (2019-2030) & (K Units)
Figure 18. Europe Monovalent Antivenom Consumption (2019-2030) & (K Units)
Figure 19. Japan Monovalent Antivenom Consumption (2019-2030) & (K Units)
Figure 20. South Korea Monovalent Antivenom Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Monovalent Antivenom Consumption (2019-2030) & (K Units)
Figure 22. India Monovalent Antivenom Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Monovalent Antivenom by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Monovalent Antivenom Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Monovalent Antivenom Markets in 2023
Figure 26. United States VS China: Monovalent Antivenom Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Monovalent Antivenom Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Monovalent Antivenom Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Monovalent Antivenom Production Market Share 2023
Figure 30. China Based Manufacturers Monovalent Antivenom Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Monovalent Antivenom Production Market Share 2023
Figure 32. World Monovalent Antivenom Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Monovalent Antivenom Production Value Market Share by Type in 2023
Figure 34. Coral Snakes Antivenom
Figure 35. Sea Snakes Antivenom
Figure 36. Brown Snake Antivenom
Figure 37. Others
Figure 38. World Monovalent Antivenom Production Market Share by Type (2019-2030)
Figure 39. World Monovalent Antivenom Production Value Market Share by Type (2019-2030)
Figure 40. World Monovalent Antivenom Average Price by Type (2019-2030) & (US$/Unit)
Figure 41. World Monovalent Antivenom Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World Monovalent Antivenom Production Value Market Share by Application in 2023
Figure 43. Non-profit Institutions
Figure 44. Hospitals and Clinic
Figure 45. World Monovalent Antivenom Production Market Share by Application (2019-2030)
Figure 46. World Monovalent Antivenom Production Value Market Share by Application (2019-2030)
Figure 47. World Monovalent Antivenom Average Price by Application (2019-2030) & (US$/Unit)
Figure 48. Monovalent Antivenom Industry Chain
Figure 49. Monovalent Antivenom Procurement Model
Figure 50. Monovalent Antivenom Sales Model
Figure 51. Monovalent Antivenom Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
CSL Merck BTG Pfizer Haffkine Bio-Pharmaceutical Vins Bioproducts Serum Biotech
Related Reports
09 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
